Hypothesis

Age-related decline in Lactonifactor-mediated equol production is not a passive loss of function but an evolved mechanism that limits post‑reproductive host physiology to benefit kin.

Mechanistic Basis

The estrobolom​e governs reactivation of conjugated estrogens and phytoestrogens, and its activity wanes with age, reducing equol synthesis from dietary daidzein [1]. Equol can bind estrogen receptors and modulate downstream signaling pathways that influence insulin/IGF‑1, mTOR, and sirtuin activity—key regulators of cellular senescence and lifespan [2]. We propose that Lactonifactor strains sense host reproductive cues (e.g., circulating estradiol levels) via quorum‑sensing molecules and adjust equol output accordingly. When host estrogen drops after menopause, reduced Lactonifactor activity lowers equol, which in turn dampens estrogenic signaling, attenuates IGF‑1 activity, and promotes a mild senescent state in somatic tissues. This physiological shift decreases host metabolic demand and reproductive competitiveness, freeing resources for younger, related individuals—a scenario compatible with kin‑selection models of aging as a selected trait.

Testable Predictions

1. Hosts with genetically elevated Lactonifactor abundance or engineered to overproduce equol will show delayed onset of age‑related biomarkers (e.g., p16^INK4a^, SA‑β‑gal) and extended lifespan compared with controls, only when reproductive capacity is intact.
2. Conversely, antibiotic‑mediated suppression of Lactonifactor in young, reproductive hosts will accelerate senescence markers and shorten lifespan, mimicking the post‑menopausal phenotype.
3. Transplanting feces from aged, low‑equol donors into germ‑free young recipients will transfer a low‑equol state and hasten age‑like phenotypes, whereas transplant from young, high‑equol donors will delay them.
4. In populations where kin competition is experimentally heightened (e.g., limited food, high relatedness), selection will favor host genotypes that support lower Lactonifactor activity, as measured by reduced equol levels in feces.

Experimental Approach

• Use gnotobiotic mice colonized with defined Lactonifactor strains (wild‑type vs. equol‑overproducing mutant). Monitor fecal equol, serum IGF‑1, and tissue senescence markers across the lifespan.
• Implement a longitudinal kin‑competition assay: house mice in family groups with limited resources; track survival, reproduction, and microbiome composition over generations.
• Perform fecal microbiota transplants between young and aged donor cohorts into germ‑free recipients, then assess equol levels, hormone signaling, and aging phenotypes.
• Apply CRISPR‑based gene editing to knock out key β‑glucuronidase genes in Lactonifactor to confirm enzymatic necessity.

If equol production by Lactonifactor actively tunes host senescence in a manner that benefits kin, then manipulating this microbial axis should shift lifespan in direction opposite to simple stochastic decay, supporting the view that aging is a deliberately preserved population-level feature rather than merely a failure of selection.